A predictive model of iron oxide nanoparticles flocculation tuning Z-potential in aqueous environment for biological application
Source abstract
Abstract
Iron oxide nanoparticles are the most used magnetic nanoparticles in biomedical and biotechnological field because of their nontoxicity respect to the other metals. The investigation of iron oxide nanoparticles behaviour in aqueous environment is important for the biological applications in terms of polydispersity, mobility, cellular uptake and response to the external magnetic field. Iron oxide nanoparticles tend to agglomerate in aqueous solutions; thus, the stabilisation and aggregation could be modified tuning the colloids physical proprieties. Surfactants or polymers are often used to avoid agglomeration and increase nanoparticles stability. We have modelled and synthesised iron oxide nanoparticles through a co-precipitation method, in order to study the influence of surfactants and coatings on the aggregation state. Thus, we compared experimental results to simulation model data. The change of Z-potential and the clusters size were determined by Dynamic Light Scattering. We developed a suitable numerical model to predict the flocculation. The effects of Volume Mean Diameter and fractal dimension were explored in the model. We obtained the trend of these parameters tuning the Z-potential. These curves matched with the experimental results and confirmed the goodness of the model. Subsequently, we exploited the model to study the influence of nanoparticles aggregation and stability by Z-potential and external magnetic field. The highest Z-potential is reached up with a small external magnetic influence, a small aggregation and then a high suspension stability. Thus, we obtained a predictive model of Iron oxide nanoparticles flocculation that will be exploited for the nanoparticles engineering and experimental setup of bioassays.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Coagulation and Flocculation Studies · Electrostatics and Colloid Interactions · Nanoparticle-Based Drug Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (89)
Show source-provided references
1. Baalousha M (2008) Aggregation and surface properties of iron oxide nanoparticles: influence of pH and natural organic matter. Environ Toxicol Chem 27(9):1875–188210.1897/07-559.1 ↗
2. Baalousha M (2009) Aggregation and disaggregation of iron oxide nanoparticles: influence of particle concentration, pH and natural organic matter. Sci Total Environ 407(6):2093–2101. doi: 10.1016/j.scitotenv.2008.11.02210.1016/j.scitotenv.2008.11.022 ↗
3. Baldassarre F, Vergaro V, Scarlino F, Santis FD, Lucarelli G, della Torre A, Ciccarella G, Rinaldi R, Giannelli G, Leporatti S (2012) Polyelectrolyte capsules as carriers for growth factor inhibitor delivery to hepatocellular carcinoma. Macromol Biosci 12(5):656–66510.1002/mabi.201100457 ↗
4. Barratt G (2003) Colloidal drug carriers: achievements and perspectives. Cell Mol Life Sci 60:21–3710.1007/s000180300002 ↗
5. Bautista M, Bomati-Miguel O, Zhao X, Morales M, Gonzàlez-Carreño T, Alejo R, Ruiz-Cabello JD, Veintemillas-Verdaguer S (2004) Comparative study of ferrofluids based on dextran-coated iron oxide and metal nanoparticles for contrast agents in magnetic resonance imaging. Nanotechnology 15:S154S15910.1088/0957-4484/15/4/008 ↗
6. Bell G, Levine S, McCartney L (1970) Approximate methods of determining the double-layer free energy of interaction between two charged colloidal spheres. J Colloid Interf Sci 33:335–35910.1016/0021-9797(70)90228-6 ↗
7. Berry C, Curtis A (2003) Functionalisation of magnetic nanoparticles for applications in biomedicine. J Phys D Appl Phys 36(13):R198–R20610.1088/0022-3727/36/13/203 ↗
8. Berry C, Wells S, Charles S, Aitchison G, Curtis A (2004) Cell response to dextran-derivatised iron oxide nanoparticles post internalisation. Biomaterials 25:54055413
9. Bulte JWM, Kraitchman D (2004) Iron oxide mr contrast agents for molecular and cellular imaging. NMR Biomed 17(7):484–499. doi: 10.1002/nbm.92410.1002/nbm.924 ↗
10. Butterworth M, Bell S, Armes S, Simpson A (1996) Synthesis and characterization of polypyrrole–magnetite–silica particles. J Colloid Interf Sci 183(1):91–99. doi: 10.1006/jcis.1996.052110.1006/jcis.1996.0521 ↗
11. Chan D, Henderson D, Barojas J, Homola A (1985) The stability of a colloidal suspension of coated magnetic particles in an aqueous solution. IBM J Res Dev 29(1):111710.1147/rd.291.0011 ↗
12. Chin CJ, Yiacoumi S, Tsouris C (1998) Shear-induced occulation of colloidal particles in stirred tanks. J Colloid Interf Sci 206(2):532–54510.1006/jcis.1998.5737 ↗
13. Cho E, Zhang Q, Xia Y (2011) The effect of sedimentation and diffusion on cellular uptake of gold nanoparticles. Nat Nanotechnol 6:385–39110.1038/nnano.2011.58 ↗
14. Chung H, Hogg R (1985) Stability criteria for fine-particle dispersions. Coll Surf 15:119–135. doi: 10.1016/0166-6622(85)80060-310.1016/0166-6622(85)80060-3 ↗
15. Cornell R, Schertmann U (1996) The iron oxides: structure, properties, reactions, occurrence and uses. Mineral Mag 61(408):740–741
16. Dickson D, L G et al (2012) Dispersion and stability of bare hematite nanoparticles: effect of dispersion tools, nanoparticle concentration, humic acid and ionic strength. Sci Total Environ 419:170–17710.1016/j.scitotenv.2012.01.012 ↗
17. Faure B, Salazar-Alvarez G, Bergström L (2011) Hamaker constants of iron oxide nanoparticles. Langmuir 27(14):8659–866410.1021/la201387d ↗
18. Fried T, Shemer G, Markovich G (2001) Ordered two-dimensional arrays of ferrite nanoparticles. Adv Mater 13:115810.1002/1521-4095(200108)13:15<1158::AID-ADMA1158>3.0.CO;2-6 ↗
19. Frienlander S, Pui D (2004) Emerging issues in nanoparticle aerosol science and technology. J Nanopart Res 6(2):313–320. doi: 10.1023/B:NANO.0000034725.89027.6b10.1023/B:NANO.0000034725.89027.6b ↗
20. Gao J, Li L, Ho P, Mak G, Gu H, Xu B (2006) Combining fluorescent probes and biofunctional magnetic nanoparticles for rapid detection of bacteria in human blood. Adv Mater 18:3145–314810.1002/adma.200601058 ↗
21. Gu H, Ho P, Tsang K, Wang L, Xu B (2003) Using biofunctional magnetic nanoparticles to capture vancomycin-resistant enterococci and other gram-positive bacteria at ultralow concentration. J Am Chem Soc 125(51):15,702–15,70310.1021/ja0359310 ↗
22. Gu H, Xu K, Xu C, Xu B (2006) Biofunctional magnetic nanoparticles for protein separation and pathogen detection. Chem Commun 9:941–949. doi: 10.1039/B514130C10.1039/b514130c ↗
23. Gupta A, Gupta M (2005) Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials 26(18):3995–4021. doi: 10.1016/j.biomaterials.2004.10.01210.1016/j.biomaterials.2004.10.012 ↗
24. Harris LA, Goff JD, Carmichael AY, Riffle JS, Harburn JJ, Pierre TGS, Saunders M (2003) Magnetite nanoparticle dispersions stabilized with triblock copolymers. Chem Mater 15(6):1367–1377. doi: 10.1021/cm020994n10.1021/cm020994n ↗
25. Hidber P, Graule T, Gauckler L (1996) Citric acid—a dispersant for aqueous alumina suspensions. J Am Ceram Soc 79(7):1857–1867. doi: 10.1111/j.1151-2916.1996.tb08006.x10.1111/j.1151-2916.1996.tb08006.x ↗
26. Honary S, Zahir F (2013) Effect of zeta potential on the properties of nano-drug delivery systems: a review (part 1). Trop J Pharm Res 12(2):255–264
27. Hu JD, Zevi Y, Kou XM, Xiao J, Wang XJ, Jin Y (2010) Effect of dissolved organic matter on the stability of magnetite nanoparticles under different pH and ionic strength conditions. Sci Total Environ 408(16):3477–3489. doi: 10.1016/j.scitotenv.2010.03.03310.1016/j.scitotenv.2010.03.033 ↗
28. Huber D (2005) Synthesis, properties, and applications of iron nanoparticles. Small 1(5):482–501. doi: 10.1002/smll.20050000610.1002/smll.200500006 ↗
29. Ito A, Tanaka K, Honda H, Abe S, Yamaguchi H, Kobayashi T (2003) Complete regression of mouse mammary carcinoma with a size greater than 15 mm by frequent repeated hyperthermia using magnetite nanoparticles. J Biosci Bioeng 96(4):364–369. doi: 10.1016/S1389-1723(03)90138-110.1016/S1389-1723(03)90138-1 ↗
30. Ito A, Hayashida M, Honda H, Hata K, Kagami H, Ueda M, Kobayashi T (2004a) Construction and harvest of multilayered keratinocyte sheets using magnetite nanoparticles and magnetic force. Tissue Eng 10:873–88010.1089/1076327041348446 ↗
31. Ito A, Takizawa Y, Honda H, Kagami HHH, Ueda M, Kobayashi T (2004b) Tissue engineering using magnetite nanoparticles and magnetic force: heterotypic layers of cocultured hepatocytes and endothelial cells. Tissue Eng 10:833840
32. Ito A, Hibino E, Kobayashi C, Terasaki H, Kagami H, Ueda M, Kobayashi T, Honda H (2005) Construction and delivery of tissue-engineering human retinal pigment epithelial cell sheets using magnetite nanoparticles and magnetic force. Tissue Eng 11:489–49610.1089/ten.2005.11.489 ↗
33. Ito A, Honda H, Kobayashi T (2006) Cancer immunotherapy based on intracellular hyperthermia using magnetite nanoparticles: a novel concept of heat-controlled necrosis with heat shock protein expression. Cancer Immunol Immunother 55(3):320–328. doi: 10.1007/s00262-005-0049-y10.1007/s00262-005-0049-y ↗
34. Jacobson M (2005) Fundamentals of atmospheric modeling, 2nd edn. Cambridge University Press, Cambridge10.1017/CBO9781139165389 ↗
35. Jiang Q, Logan B (1991) Fractal dimensions of aggregates determined from steady-state size distributions. Environ Sci Technol 25(12):2031–2038. doi: 10.1021/es00024a00710.1021/es00024a007 ↗
36. Kato H, Suzuki M, Fujita K, Horie M, Endoh S, Yoshida Y, Iwahashi H, Takahashi K, Nakamura A, Kinugasa S (2009) Reliable size determination of nanoparticles using dynamic light scattering method for in vitro toxicology assessment. Toxicol In Vitro 23(5):927–934. doi: 10.1016/j.tiv.2009.04.00610.1016/j.tiv.2009.04.006 ↗
37. Kell A, Stewart G, Ryan S, Peytavi R, Boissinot M, Huletsky A, Bergeron M, Simard B (2008) Vancomycin-modified nanoparticles for efficient targeting and preconcentration of gram-positive and gram-negative bacteria. ACS Nano 2(9):1777–1788. doi: 10.1021/nn700183g10.1021/nn700183g ↗
38. Kendall K, Kendall M, Rehfeldt F (2011a) Adhesion of nanoparticles. Adhesion of cells. Viruses and nanoparticles. Springer, Netherlands10.1007/978-90-481-2585-2 ↗
39. Kendall K, Kendall M, Rehfeldt F (2011b) Modelling nanoparticle, virus and cell adhesion. Adhesion of cells. Viruses and nanoparticles. Springer, Netherlands10.1007/978-90-481-2585-2 ↗
40. Kusters K (1991) The influence of turbulence on aggregation of small particles in agitated vessels. PhD thesis, Eindhoven University of Technology, The Netherlands
41. Larsen B, Haag M, Serkova N, Shroyer K, Stoldt C (2008) Controlled aggregation of superparamagnetic iron oxide nanoparticles for the development of molecular magnetic resonance imaging probes. Nanotechnology 19(26):265102, http://stacks.iop.org/0957-4484/19/i=26/a=26510210.1088/0957-4484/19/26/265102 ↗
42. Laurent S, Dutz S, Häfeli U, Mahmoudi M (2011) Magnetic fluid hyperthermia: focus on superparamagnetic iron oxide nanoparticles. Adv Colloid Interf Sci 166(1–2):8–23. doi: 10.1016/j.cis.2011.04.00310.1016/j.cis.2011.04.003 ↗
43. Leeuwenburgh S, Ana I, Jansen J (2010) Sodium citrate as an effective dispersant for the synthesis of inorganic–organic composites with a nanodispersed mineral phase. Acta Biomater 6(3):836–844. doi: 10.1016/j.actbio.2009.09.00510.1016/j.actbio.2009.09.005 ↗
44. Leroux J (2007) Injectable nanocarriers for biodetoxification. Nat Nanotechnol 2:679–68410.1038/nnano.2007.339 ↗
45. Li Z, Wei L, Gao M, Lei H (2005) One-pot reaction to synthesize biocompatible magnetite nanoparticles. Adv Mater 17(8):1001–1005. doi: 10.1002/adma.20040154510.1002/adma.200401545 ↗
46. Lübbe A, Bergemann C, Riess H, Schriever F, Reichardt P, Possinger K, Matthias M, Dörken B, Herrmann F, Gürtler R, Hohenberger P, Haas N, Sohr R, Sander B, Lemke AJ, Ohlendorf D, Huhnt W, Huhn D (1996) Clinical experiences with magnetic drug targeting: a phase i study with 4-epidoxorubicin in 14 patients with advanced solid tumors. Cancer Res 56(20):4686–4693, http://cancerres.aacrjournals.org/content/56/20/4686.abstract
47. Mancarella S, Greco V, Baldassarre F, Vergara D, Maffia M, Leporatti S (2015) Polymer-coated magnetic nanoparticles for curcumin delivery to cancer cells. Macromol Biosci. doi: 10.1002/mabi.20150014210.1002/mabi.201500142 ↗
48. Mendelev V, Ivanov A (2005) Magnetic properties of ferrofluids: an influence of chain aggregates. J Magn Magn Mater 289:211–214. doi: 10.1016/j.jmmm.2004.11.06110.1016/j.jmmm.2004.11.061 ↗
49. Mikhaylova M, Kim D, Bobrysheva N, Osmolowsky M, Semenov V, Tsakalakos T, Muhammed M (2004) Superparamagnetism of magnetite nanoparticles: dependence on surface modification. Langmuir 20(6):2472–2477. doi: 10.1021/la035648e10.1021/la035648e ↗
50. Mornet S, Vasseur S, Grasset F, Duguet E (2004) Magnetic nanoparticle design for medical diagnosis and therapy. J Mater Chem 14:2161–2175. doi: 10.1039/B402025A10.1039/b402025a ↗
51. Neuberger T, Schöpf B, Hofmann H, Hofmann M, von Rechenberg B (2005) Superparamagnetic nanoparticles for biomedical applications: possibilities and limitations of a new drug delivery system. J Magn Magn Mater 293(1):483–496. doi: 10.1016/j.jmmm.2005.01.064 (proceedings of the Fifth International Conference on Scientific and Clinical Apllications of Magnetic Carriers)10.1016/j.jmmm.2005.01.064 ↗
52. Nobuto H, Sugita T, Kubo T, Shimose S, Yasunaga Y, Murakami T, Ochi M (2004) Evaluation of systemic chemotherapy with magnetic liposomal doxorubicin and a dipole external electromagnet. Int J Cancer 109(4):627–635. doi: 10.1002/ijc.2003510.1002/ijc.20035 ↗
53. Papaefthymiou G (2009) Nanoparticle magnetism. Nano Today 4(5):438–447, doi: 10.1016/j.nantod.2009.08.006 , http://www.sciencedirect.com/science/article/pii/S174801320900092910.1016/j.nantod.2009.08.006 ↗
54. Ponder S, Darab J, Mallouk T (2000) Remediation of cr(vi) and pb(ii) aqueous solutions using supported, nanoscale zero-valent iron. Environ Sci Technol 34(12):2564–2569. doi: 10.1021/es991142010.1021/es9911420 ↗
55. Roca A, Veintemillas-Verdaguer S, Port M, Robic C, Serna C, Morales M (2009) Effect of nanoparticle and aggregate size on the relaxometric properties of mr contrast agents based on high quality magnetite nanoparticles. J Phys Chem B 113(19):7033–7039. doi: 10.1021/jp807820s10.1021/jp807820s ↗
56. Rolliè S, Briesen J, Sundmacher K (2009) Discrete bivariate population balance modelling of heteroaggregation processes. J Colloid Interf Sci 336(2):551–564. doi: 10.1016/j.jcis.2009.04.03110.1016/j.jcis.2009.04.031 ↗
57. Ruysschaert T, Paquereau L, Winterhalter M, Fournier D (2006) Stabilization of liposomes through enzymatic polymerization of dna. Nano Lett 6(12):2755–2757. doi: 10.1021/nl061724x10.1021/nl061724x ↗
58. Safarik I, Safarikova M (2004) Magnetic techniques for the isolation and purification of proteins and peptides. Biomagn Res Technol 2:710.1186/1477-044X-2-7 ↗
59. Saffman P, Turner J (1956) On the collision of drops in turbulent clouds. J Fluid Mech 1:16–30. doi: 10.1017/S002211205600002010.1017/S0022112056000020 ↗
60. Saiyed Z, Telang S, Ramchand C (2003) Application of magnetic techniques in the field of drug discovery and biomedicine. Biomagn Res Technol 1:210.1186/1477-044X-1-2 ↗
61. Saleh N, Phenrat T, Sirk K, Dufour B, Ok J, Sarbu T, Matyjaszewski K, Tilton R, Lowry G (2005) Adsorbed triblock copolymers deliver reactive iron nanoparticles to the oil/water interface. Nano Lett 5(12):2489–2494. doi: 10.1021/nl051826810.1021/nl0518268 ↗
62. Sayes C, Reed K, Warheit DB (2007) Assessing toxicity of fine and nanoparticles: comparing in vitro measurements to in vivo pulmonary toxicity profiles. Toxicol Sci 97(1):163–180, doi: 10.1093/toxsci/kfm018 , http://toxsci.oxfordjournals.org/content/97/1/163.abstract , http://toxsci.oxfordjournals.org/content/97/1/163.full.pdf+html10.1093/toxsci/kfm018 ↗
63. Selomulya C, Bushell G, Amal R, Waite T (2003) Understanding the role of restructuring in flocculation: the application of a population balance model. Chem Eng Sci 58(2):327–338, doi: 10.1016/S0009-2509(02)00523-7 , http://www.sciencedirect.com/science/article/pii/S000925090200523710.1016/S0009-2509(02)00523-7 ↗
64. Shafi K, Ulman A, Yan X, N-LYang, Estournés C, White H, Rafailovich M (2001) Sonochemical synthesis of functionalized amorphous iron oxide nanoparticles. Langmuir 17(16):5093–5097. doi: 10.1021/la010421+10.1021/la010421+ ↗
65. Shen L, Laibinis P, Hatton T (1999) Bilayer surfactant stabilized magnetic fluids: synthesis and interactions at interfaces. Langmuir 15:447–45310.1021/la9807661 ↗
66. Shinkai M, Le B, Honda H, Yoshikawa K, Shimizu K, Saga S, Wakabayashi T, Yoshida J, Kobayashi T (2001) Targeting hyperthermia for renal cell carcinoma using human mn antigen-specific magnetoliposomes. Jpn J Cancer Res 92:1138–114510.1111/j.1349-7006.2001.tb01070.x ↗
67. Smoluchowski M (1916) Drei vortrge ber diffusion, brownsche molekularbewegung und koagulation von kolloidteilchen. JPhys Zeit 17:557571
68. Sousa M, Tourinho F, Depeyrot J, da Silva G, Lara M (2001) New electric double-layered magnetic fluids based on copper, nickel, and zinc ferrite nanostructures. J Phys Chem B 105(6):1168–1175. doi: 10.1021/jp003916110.1021/jp0039161 ↗
69. Spielman L (1970) Viscous interactions is brownian coagulation. J Colloid Interf Sci 33(4):562–57010.1016/0021-9797(70)90008-1 ↗
70. Sun YP, q Li X, Cao J, x Zhang W, Wang H (2006) Characterization of zero-valent iron nanoparticles. Adv Colloid Interf Sci 120(1–3):47 56. doi: 10.1016/j.cis.2006.03.001
71. Suzuki M, Shinkai M, Honda H, Kobayashi T (2003) Anticancer effect and immune induction by hyperthermia of malignant melanoma using magnetite cationic liposomes. Melanoma Res 13:129–13510.1097/00008390-200304000-00004 ↗
72. Taboada-Serrano P, Chin CJ, Yiacoumi S, Tsouris C (2005) Modeling aggregation of colloidal particles. Curr Opin Colloid Interf Sci 10(3–4):123–13210.1016/j.cocis.2005.07.003 ↗
73. Tanimoto A, Oshio K, Suematsu M, Pouliquen D, Stark D (2001) Relaxation effects of clustered particles. J Magn Reson Imaging 14(1):72–77. doi: 10.1002/jmri.115310.1002/jmri.1153 ↗
74. Tartaj P, del Puerto Morales M, Veintemillas-Verdaguer S, Gonzàlez-Carreño T, Serna C (2003) The preparation of magnetic nanoparticles for applications in biomedicine. J Phys D Appl Phys 36(13):R18210.1088/0022-3727/36/13/202 ↗
75. Tartaj P, del Puerto Morales M, Gonzàlez-Carreño T, Veintemillas-Verdaguer S, Serna C (2005) Advantages in magnetic nanoparticles for biotechnology applications. J Magn Magn Mater 28:290–291
76. Teeguarden J, Hinderliter P, Orr G, Thrall B, Pounds J (2007) Particokinetics in vitro: dosimetry considerations for in vitro nanoparticle toxicity assessments. Toxicol Sci 95(2):300–312, doi: 10.1093/toxsci/kfl165 , http://toxsci.oxfordjournals.org/content/95/2/300.abstract10.1093/toxsci/kfl165 ↗
77. Thomas D, Judd S, Fawcett N (1999) Flocculation modelling: a review. Water Res 33(7):1579–159210.1016/S0043-1354(98)00392-3 ↗
78. Thünemann A, Schütt D, Kaufner L, Pison U, Möhwald H (2006) Maghemite nanoparticles protectively coated with poly(ethylene imine) and poly(ethylene oxide)-block-poly(glutamic acid). Langmuir 22(5):2351–2357. doi: 10.1021/la052990d10.1021/la052990d ↗
79. Tietze S, Duerr S, Alexiou C (2012) Nanoparticles for cancer therapy using magnetic forces. Nanomedicine 7(3):447–45710.2217/nnm.12.10 ↗
80. Tsouris C, Scott T (1995) Flocculation of paramagnetic particles in a magnetic field. J Colloid Interf Sci 171(2):319–33010.1006/jcis.1995.1186 ↗
81. Verma A, Stellacci F (2010) Effect of surface properties on nanoparticlecell interactions. Small 6(1):12–2110.1002/smll.200901158 ↗
82. Vishista K, Gnanam F (2004) Role of deflocculants on the rheological properties of boehmite sol. Mater Lett 58:1576–8110.1016/j.matlet.2003.10.029 ↗
83. Wan M, Li J (1998) Synthesis and electrical–magnetic properties of polyaniline composites. Polymer Sci 36:2799–2805
84. Widder K, Senyei A, Scarpelli D (1978) Magnetic microspheres: a model system for site specific drug delivery in vivo. Proc Soc Exp Biol Med 58:14110.3181/00379727-158-40158 ↗
85. Wiesner M (1992) Kinetics of aggregate formation in rapid mix. Water Res 26(3):379–38710.1016/0043-1354(92)90035-3 ↗
86. Ying T, Yacoumi S, Tsouris C (2000) High-gradient magnetically seeded filtration. Chem Eng Sci 55(6):1101–111310.1016/S0009-2509(99)00383-8 ↗
87. Zhang J, Srivastava R, Misra R (2007) Core–shell magnetite nanoparticles surface encapsulated with smart stimuli-responsive polymer: synthesis, characterization, and lcst of viable drug-targeting delivery system. Langmuir 23(11):6342–6351. doi: 10.1021/la063619910.1021/la0636199 ↗
88. Zhang L, Granick S (2006) How to stabilize phospholipid liposomes (using nanoparticles). Nano Lett 6:694–69810.1021/nl052455y ↗
89. Zhu D, Liu F, Ma L, Liu D, Wang Z (2013) Nanoparticle-based systems for t1-weighted magnetic resonance imaging contrast agents. Int J Mol Sci 14(5):10,591–10,607, doi: 10.3390/ijms140510591 , http://www.mdpi.com/1422-0067/14/5/1059110.3390/ijms140510591 ↗